Biologics Flashcards
Traditional drugs
- synthetic organic compounds
- defined structure, physical and chemical characteristics
- small MW
- linear dose response
- biotransformed
- NOT species specific
Biologics
- protein, carb, nucleic acid structures
- extracted from living organism
- large MW
- heat and shear sensitive
- non linear dose response
- species dependent
u
human
o
mouse
xi
chimeric
zu
humanized
Biologics elimination
RES
antigen specific target mediated disposition
Common side effects of biologics
- infusion site reactions
- allergic reactions
- flu like symptoms
- N/D
- decreased blood cell counts
Etanercept
- anti-TNF
- TNF receptor
- shortest DOA
- RA, psoriasis, psoriatic arthritis
Side effects etanercept
Ha, allergic reaction, rash, URI
BBW anti TNF drugs
for serious infections, malignancies
Infliximab
- anti-TNF
- partially humanized
- Crohn’s disease, ulcerative colitis
Infliximab side effects
CV effects
adalimumab
- anti-TNF
- fully humanized
Adalimumab side effects
- develop antibodies against drug
- cause demyelination
CI adalimumab
patients with demyelinating diseases (MS)
bevacizumab
- angiogenesis inhibitor
- stops formation of new blood vessels, inhibit VEGF
- treat cancers, eye diseases
BBW bevacizumab
hemorrhage, delayed wound healing and GI perforations
Abciximab
- GPIIb/IIIa antagonist
- prevent platelet aggregation
- percutaneous coronary intervention
Side effects abciximab
- bleeding
- thrombocytopenia
- allergy
Omalizumab
- IgE inhibitor
- moderate to severe asthma
BBW omalizumab
for anaphylaxis presenting as bronchospasm
side effects omalizumab
- injection site reactions
- CV events
Pembrolizumab
- Block PD1
- humanized
- cancers
Side effects pembrolizumab
- rash (SJS)
- fatigue
- T1D
Nivolumab
- block PD1
- fully human
- metastatic cancer
Side effects of nivolumab
- Rash (SJS)
- adrenal insufficiency
- T1D
- GI toxicity: diarrhea, colitis
What can nivolumab be used with?
ipilimumab (synergistic)
- metastatic melanoma
Atezolizumab
- block PD-L1
- humanized
- metastatic lung cancer
- metastatic urothelial carcinoma
Side effects of anti PD-L1 drugs
- adrenal insufficiency
- CV toxicity
- T1D
- infection risks
avelumab
- block PD-L1
- fully human
- Merkel cell carcinoma
- advanced metastatic urothelial carcinoma
durvalumab
- block PD-L1
- fully human
- metastatic urothelial carcinoma
Ipilimumab
- CTLA-4 inhibitor
- fully human
- metastatic and non-metastatic melanoma
BBW ipilimumab
- immune mediated reactions (months to weeks after treatment stops)
CTLA-4 inhibitor drugs
ipilimumab
PD-L1 inhibitor drugs
- atezolizumab
- avelumab
- durvalumab
PD-1 inhibitor drugs
- pembrolizumab
- nivolumab
IgE inhibitor drugs
- omalizumab
Anti platelet drugs
- abciximab
Malignancies drugs
- bevacizumab
Anti-TNF drugs
- etanercept
- infliximab
- adalimumab